DS
IMGO

David Shaw’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

David Shaw’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,058
Closed -$760K – 6159
2021
Q4 		$760K Buy
+32,058
New +$743K ﹤0.01% 4139

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

David Shaw's IMGO Position: Q1 2022 in Review

David Shaw sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2022, closing a stake of 32,058 shares — an estimated $760K sold.

David Shaw first reported a position in IMGO in Q4 2021 and held it in 1 quarter. The position peaked at $760K in Q4 2021. 59 funds tracked by Wall St. Rank hold IMGO as of Q1 2022.

  • David Shaw reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2022 after selling out during the quarter.
  • David Shaw sold 32,058 Imago BioSciences, Inc. Common stock shares in Q1 2022, an estimated $760K.
  • David Shaw first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 1 quarter.
  • David Shaw's Imago BioSciences, Inc. Common stock position peaked at $760K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.